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ABSTRACT 
Objective 
To identify clinical features associated with PE diagnosis and determine the accuracy of decision 
rules and D-dimer for diagnosing suspected PE in pregnant/postpartum women 
 
Design 
Observational cohort study augmented with additional cases 
 
Setting 
Emergency departments and maternity units at eleven prospectively recruiting sites and maternity 
units in the United Kingdom Obstetric Surveillance System (UKOSS) 
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Population 
324 pregnant/postpartum women with suspected PE and 198 pregnant/postpartum women with 
diagnosed PE 
 
Methods 
We recorded clinical features, elements of clinical decision rules, D-dimer measurements, imaging 
results, treatments and adverse outcomes up to 30 days 
 
Main outcome measures 
Women were classified as having PE on the basis of imaging, treatment and adverse outcomes by 
assessors blind to clinical features and D-dimer. Primary analysis was limited to women with 
conclusive imaging to avoid work-up bias. Secondary analyses included women with clinically 
diagnosed or ruled out PE. 
 
Results 
The only clinical features associated with PE on multivariate analysis were age (odds ratio 1.06; 95% 
confidence interval 1.01-1.11), previous thrombosis (3.07; 1.05-8.99), family history of thrombosis 
(0.35; 0.14-0.90), temperature (2.22; 1.26-3.91), systolic blood pressure (0.96; 0.93-0.99), oxygen 
saturation (0.87; 0.78-0.97) and PE-related chest x-ray abnormality (13.4; 1.39-130.2). 
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Clinical decision rules had areas under the receiver-operator characteristic curve ranging from 0.577 
to 0.732 and no clinically useful threshold for decision-making. Sensitivities and specificities of D-
dimer were 88.4% and 8.8% using a standard threshold and 69.8% and 32.8% using a pregnancy-
specific threshold. 
 
Conclusions 
Clinical decision rules and D-dimer should not be used to select pregnant or postpartum women with 
suspected PE for further investigation. Clinical features and chest x-ray appearances may have 
counter-intuitive associations with PE in this context. 
 
Funding  
National Institute for Health Research Health Technology Assessment Programme (13/21/01) 
 
Keywords 
 
Pulmonary embolism, pregnancy, postpartum, clinical decision rule, D-dimer 
Tweetable abstract 
Clinical decision rules and D-dimer are not helpful for diagnosing pregnant/postpartum women with 
suspected PE 
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Study registration 
ISRCTN registry ISRCTN21245595 (http://www.isrctn.com/ISRCTN21245595)  
 
INTRODUCTION 
Pulmonary embolism (PE) is the leading direct cause of death in pregnancy and postpartum
1
. 
Symptoms suggesting PE are common in pregnancy and postpartum. Suspected PE is therefore a 
common presentation to emergency departments and maternity units by pregnant and postpartum 
women. Recent studies
2
 have reported a low positive yield from investigation so many women are 
undergoing negative imaging involving potentially harmful radiation. Guidelines from the American 
Thoracic Society
3
 and Royal College of Obstetricians and Gynaecologists
4
 recommend that all 
pregnant and postpartum women with suspected PE should receive diagnostic imaging, whereas 
guidelines from the European Society of Cardiology
5
 suggest a possible role for D-dimer in selecting 
patients. 
 
Clinical decision rules use features of the patient history and examination to estimate the probability 
of PE in people with suspected PE
6-8
. Plasma D-dimers are specific cross-linked fibrin derivatives 
produced when fibrin is degraded by plasmin, elevated levels indicating thrombolysis. They are 
elevated in venous thromboembolism (VTE) but also in other conditions such as pregnancy, pre-
eclampsia, infections, malignancy and postoperative states. Clinical decision rules and D-dimer have 
been shown to accurately identify low risk patients in the non-pregnant population with suspected 
PE who can be discharged without diagnostic imaging, and guidelines now recommend this 
practice
5,9
. 
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A recent review
2
 found insufficient data to support a similar role for clinical decision rules and D-
dimer in pregnant and postpartum women. The main limitation was the low prevalence of PE in 
cohorts with suspected PE and consequent lack of precision in estimates of diagnostic sensitivity. 
Low prevalence means that the ideal study design to estimate diagnostic accuracy, a cohort study, 
would provide an imprecise estimate of sensitivity unless it was extremely large. A case-control 
study could provide a more precise estimate, albeit with a higher risk of bias
10
. A compromise 
between these designs is a cohort study augmented with additional cases of confirmed disease to 
increase the precision of estimates of sensitivity. 
 
We undertook a prospective cohort study augmented with additional retrospective cases to 
determine whether clinical features, individually or in the form of a clinical decision rule, or D-dimer 
could be used to select pregnant and postpartum women for diagnostic imaging. 
METHODS 
Study population 
We identified participants from two sources over the same time period: (1) Emergency departments 
and maternity units at eleven prospectively recruiting sites identified women presenting with 
suspected PE during pregnancy or postpartum; (2) The United Kingdom (UK) Obstetric Surveillance 
System (UKOSS) research platform was used to retrospectively identify women across all UK 
hospitals who received a diagnosis of PE during pregnancy or postpartum (up to 42 days). We 
excluded women who presented needing life support on arrival at hospital from both groups; 
women whose PE was identified as an incidental finding from the diagnosed PE group; and women 
who had been diagnosed with PE in the current pregnancy before the start of the study, were unable 
or unwilling to provide informed consent, aged less than 16 years or previously recruited to the 
study from the suspected PE group. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The diagnosed PE group were identified as (1) PE confirmed using imaging (angiography, CT, 
magnetic resonance imaging or ventilation Wperfusion scan showing a high probability of PE), (2) PE 
confirmed at surgery or post-mortem, or (3) Clinical diagnosis of PE resulting in a course of 
anticoagulation therapy for more than one week, although the third group was only included in 
secondary analysis. The suspected PE group were identified if a clinician determined that 
investigation for PE would be required. This resulted in most cases receiving diagnostic imaging but a 
proportion did not, either due to a more senior clinician deciding that imaging was not indicated or 
the woman declining imaging. Furthermore a proportion of women in both groups had equivocal 
imaging results. Thus both the diagnosed PE and suspected PE groups included a proportion of 
women in whom PE was clinically diagnosed or ruled out (i.e. without definitive imaging, surgery or 
post-mortem). We planned a priori that primary analysis would be limited to women with imaging, 
surgery or post-mortem confirmation or rule-out of PE with secondary analyses exploring the 
inclusion of women with clinically diagnosed or ruled out PE. Our rationale was that clinical diagnosis 
could be based on the index tests we were planning to evaluate and would thus be prone to bias. 
 
Sampling 
Suspected PE: Clinicians in the participating hospitals prospectively identified pregnant or 
postpartum woman with suspected PE considered to require diagnostic imaging. They contacted the 
research nurse or recruiting clinician, who provided women with study information and checked 
eligibility criteria. Informed consent to participate was then sought. 
 
Diagnosed PE: Nominated clinicians in each consultant-led maternity unit in the UK were sent a card 
each month and asked to report all cases of antenatal or postnatal PE. In addition, ascertainment of 
any maternal deaths from PE occurring during the study period was checked through MBRRACE-UK, 
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the collaboration responsible for the UK Confidential Enquiries into Maternal Death. Where a case 
was identified, the UKOSS clinician was contacted and asked to complete a data collection form if 
appropriate.  
 
It was not practicable to obtain consent for data collection from individual women with diagnosed 
PE. Names, addresses, postcodes, dates of birth and hospital numbers were therefore not collected 
in the UKOSS research platform, in accordance with guidance from the relevant regulatory bodies 
that organisations seeking to use information for research purposes without consent should not use 
any personally identifiable information. 
 
Data collection 
UKOSS clinicians and research nurses/midwives collected data from the hospitals records of the 
diagnosed and suspected PE groups respectively. We collected details of clinical features (including 
past medical history, previous pregnancies, current pregnancy, risk factors for VTE, presenting 
symptoms, clinical signs and physiological measures), D-dimer measurements (along with the 
laboratory reference standard), reports from diagnostic imaging, treatments for VTE, adverse events 
and any findings from surgery for PE or post-mortem. 
 
The suspected PE group were also followed up at 30 days after recruitment by hospital record 
review and questionnaire survey to record any additional adverse events or health care. Where 
insufficient information or was obtained to verify status at 30 days ƚŚĞǁŽŵĂŶ ?Ɛprimary care 
physician was contacted and asked to provide details of additional investigations or events using 
primary care records. 
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Women recruited with suspected PE who were subsequently diagnosed with PE were cross-checked 
with the UKOSS cases to avoid duplication. In such cases data collected by the research 
nurses/midwives were used. 
 
Index tests 
Clinical features were classified a priori as present or absent, usually on the basis of the expected 
association between the feature and risk of having PE. For continuous variables we also identified a 
threshold to allow categorisation of the variable. 
 
We tested three clinical decision rules that were developed through expert consensus in an earlier 
phase of the study
11
. These included a primary rule, in which the experts aimed for an optimal 
balance of sensitivity and specificity, along with sensitive and specific rules that optimised sensitivity 
and specificity respectively. Developing a clinical decision rule inevitably involves a trade-off 
between sensitivity (avoiding missing women with PE) and specificity (avoiding over-investigating 
women without PE). The three rules were developed to explore this trade-off with the primary rule 
intended to achieve high sensitivity without sacrificing specificity to the extent that nearly all women 
would be investigated. The expert derived decision rules are described in appendix S1. 
We took three existing clinical decision rules, the PERC rule
6
, ƚŚĞtĞůů ?ƐWĐƌŝƚĞƌŝĂ7 and the 
simplified revised Geneva score
8
, and adapted them for a pregnant or postpartum population by 
using pregnancy-specific thresholds for age, oxygen saturation and heart rate, and removing 
exogenous oestrogen from the PERC rule. We also created ƚǁŽǀĞƌƐŝŽŶƐŽĨƚŚĞtĞůů ?ƐĐƌŝƚĞƌŝĂ
depending upon whether a strict or permissive interpretation was used for the criterion that an 
alternative diagnosis is less likely than PE. 
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D-dimer measurements were recorded for some women as part of routine care. Samples were 
analysed in different hospitals, using different assays with different diagnostic thresholds. 
Furthermore we expected specificity to decline with gestational age. We therefore planned to test a 
threshold for positivity for D-dimer using the hospital laboratory threshold during the first trimester, 
1.5x the laboratory threshold for the second trimester and 2x the laboratory threshold for the 3rd 
trimester, based on data showing how D-dimer levels increase during pregnancy
12
 and evidence that 
a higher threshold may improve specificity for diagnosing VTE in pregnancy without sacrificing 
sensitivity
13
. 
 
Reference standard 
Two independent assessors (SG,CNP), blind to clinical features and D-dimer measurements, used a 
structured process to classify diagnostic imaging results, adverse events and treatments, and thus 
classify all women as PE present or PE absent. This process was also used to determine whether they 
were included in the primary analysis (PE confirmed or ruled out by imaging, surgery or post-
mortem) or secondary analysis (PE clinically diagnosed or ruled out). Details of the process are 
described in appendix S2. 
 
Sample size 
The sample size was inevitably determined by the incidence of diagnosed and suspected PE during 
the data collection period. Based on a previous study
14
 we anticipated that we would identify 150 
cases with diagnosed PE over 18 months. We aimed to recruit 250 women with suspected PE over 
the same time period, resulting in about 155 cases with PE and 245 controls without, assuming 
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prevalence of 2% in those with suspected PE. This would allow estimation of sensitivity or specificity 
of 90% with a standard error of about 2.5% and 2.0% respectively. Assuming that the ratio of cases 
to controls would be about 0.4, then this sample size would be sufficient to identify an odds ratio of 
a clinical predictor of about 2, with 90% power and 5% two sided significance
15
. 
 
Analysis 
Univariable logistic regression was used to determine the association between each clinical feature 
and the presence or absence of PE. Multivariate regression was performed adjusting for all other 
variables. Where the same variable was analysed in dichotomised and continuous form in the 
univariate analysis only the continuous variable was included in the multivariate analysis. Where 
 “ŽƚŚĞƌ ?ĐĂƚĞŐŽƌŝĞƐof previous medical problems and current pregnancy problems were classified as 
any other problem or VTE-related other problem in the univariate analysis only VTE-related 
categorisation was used in the multivariate analysis. We also tested the association between receipt 
of thromboprophylaxis and PE. Thromboprophylaxis is provided on the basis of VTE so it could be a 
marker for VTE risk, although it is intended to reduce VTE risk.  
 
Diagnostic accuracy of each clinical decision rule was assessed by plotting a receiver-operator 
characteristic (ROC) curve and calculating the area under the curve (AUC). Sensitivity and specificity 
were calculated for each clinical decision rule using the recommended or standard threshold, and for 
D-dimer using the threshold outlined above. Univariable logistic regression and D-dimer analysis 
were limited to cases with complete data. For the clinical decision rule analysis missing variables in 
the rule were imputed as normal or negative, unless more than one of heart rate, respiratory rate 
and oxygen saturation were missing or more than half of the predictors relating to previous medical 
history or the current pregnancy were missing, in which circumstance the case was excluded. 
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Patient involvement 
Patient representatives from Thrombosis UK and the Sheffield Emergency Care Forum advised on 
development of the protocol, reviewed all patient and public facing material and were members of 
the study steering committee. 
 
Funding 
The DiPEP study was funded by the United Kingdom National Institute for Health Research Health 
Technology Assessment (HTA) programme (project reference 13/21/01). The research question was 
prioritised by the HTA programme commissioning process with patient and public involvement. 
Funding was granted following a competitive commissioning process that included external peer 
review for scientific quality. The funder played no subsequent role in conducting the research or 
writing the paper. 
 
RESULTS 
Between 1 March 2015 and 31 August 2016 we recruited 324 women with suspected PE across the 
prospectively recruiting sites. Screening identified an additional 35 women who were unable or 
unwilling to give consent and 95 who were eligible but not approached to participate. Over the same 
time period we identified 224 women with diagnosed PE through the UKOSS research platform. We 
excluded 21 who had or may have presented with life threatening features and five who were also 
identified through the suspected PE group, leaving 198 for analysis.  
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Figure S1 shows the flow of patients recruited and analysed in the study. And table S1 shows the 
characteristics of the women with diagnosed PE, the recruited women with suspected PE and the 
women with suspected PE who were eligible but not asked to participate. 
 
The 324 women with suspected PE consisted of 18 with PE confirmed by imaging, five with clinically 
diagnosed PE (three with equivocal imaging and two with no imaging; all treated), 259 with PE ruled 
out with imaging (254 with negative imaging and five untreated after equivocal imaging) and 42 with 
PE clinically ruled out without imaging (none treated). The 198 women with diagnosed PE consisted 
of 163 with PE confirmed by imaging or post-mortem (160 imaging, two post mortem and one both) 
and 35 with clinically diagnosed PE (29 with equivocal imaging and six with no imaging recorded; all 
treated).  Thus the primary analysis population included 181 women with PE and 259 without PE. 
 
Table 1 compares the characteristics between women with and without PE, and reports the 
univariate and multivariate odds ratio, 95% CI and p-value for each comparison. Table 2 reports the 
same analysis comparing presenting features, physiology, ECG and chest x-ray. There were few 
differences between the women with and without PE. The only features significantly associated with 
PE (p<0.05) in univariate analysis were number of previous pregnancies beyond 24 weeks, surgery in 
the previous four weeks (including caesarean section), no history of varicose veins, no long haul 
travel during pregnancy, higher temperature, lower oxygen saturation and chest x-ray abnormality 
(both PE related and non PE related). In the multivariate analysis age (odds ratio 1.06; 95% 
confidence interval 1.01-1.11), previous thrombosis (3.07; 1.05-8.99), family history of thrombosis 
(0.35; 0.14-0.90), temperature (2.22; 1.26-3.91), systolic blood pressure (0.96; 0.93-0.99), oxygen 
saturation (0.87; 0.78-0.97) and PE-related chest x-ray abnormality (13.4; 1.39-130.2) were 
associated with PE. A higher proportion of women with PE had received thromboprophylaxis 
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(88/181 (48.62%) versus 70/259 (27.03%) and receipt of thromboprophylaxis was associated with PE 
(odds ratio 2.56; 95% CI 1.72-3.82; p<0.001). Table 3 compares the summary measures of each 
continuous clinical variable. There was little difference between women with and without PE. 
 
Table 4 reports the diagnostic accuracy of each clinical decision rule and figure S2 shows the ROC 
curve. Full results for each score are shown in appendix S3. Diagnostic accuracy was generally poor. 
The sensitive expert consensus rule had good sensitivity (95%) but very poor specificity (4%), 
showing that sensitivity was only achieved by setting a very low threshold fŽƌƉŽƐŝƚŝǀŝƚǇ ?dŚĞtĞůů ?Ɛ
PE criteria may have some modest diagnostic value if the criterion that an alternative diagnosis is 
less likely than PE is applied in a strict way, i.e. it is only positive if PE is clearly considered the most 
likely or equal most likely diagnosis. Figure S2 and appendix S3 show that there is no threshold for 
decision making that achieves high sensitivity without sacrificing specificity to an unacceptable 
degree. 
 
D-dimer measurements were recorded as part of routine care for 44/198 (22%) women with 
diagnosed PE and 156/324 (48%) women with suspected PE. After exclusion of 22 women with 
clinically diagnosed or ruled out PE and 10 women with no D-dimer threshold recorded the primary 
analysis data set for those with routine care D-dimer measurements consisted of 43 women with PE 
and 125 without. The sensitivity and specificity (n/N, 95% CI) using the hospital laboratory threshold 
was 88.4% (38/43, 74.1 to 95.6) and 8.8% (11/125, 4.7 to 15.6) respectively. The sensitivity and 
specificity (95% CI) using the pregnancy specific threshold was 69.8% (30/43, 53.7 to 82.3) and 32.8% 
(41/125, 24.8 to 41.9) respectively. 
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The results of the secondary analyses are reported in appendix S4. They showed no meaningful 
differences to the primary analysis. 
 
DISCUSSION 
Main findings 
We found that a number of risk factors for VTE have little diagnostic value and some may even be 
misleading when used in the diagnostic assessment of pregnant and postpartum women referred to 
hospital for suspected PE. History of varicose veins, family history of VTE and recent long haul travel 
are known risk factors for VTE but were more common in women with suspected PE who had PE 
ruled out than those with diagnosed PE, although only family history of VTE was associated with 
absence of PE on multivariate analysis. It is possible that the presence of risk factors led to an 
increased likelihood of presentation to or referral to secondary care. Presenting clinical features 
were unhelpful in diagnosing PE, while oxygen saturation, systolic blood pressure and temperature 
were the only physiological measures associated with PE. Chest x-ray abnormalities that were not 
considered to be PE-related were more frequent in women with PE, although only PE-related 
abnormalities were associated with PE on multivariate analysis. These findings suggest that we need 
to reconsider the way we interpret the clinical assessment of pregnant or postpartum women 
attending hospital with suspected PE. 
 
We also found that existing clinical decision rules have little discriminant value in the assessment of 
suspected PE in pregnancy and postpartum. The AUCs for all but one of the rules were close to 0.5 
indicating discriminant value little better than chance.  OŶůǇƚŚĞtĞůů ?ƐWĐƌŝƚĞƌŝĂǁŝƚŚĂƐƚƌŝĐƚ
interpretation of whether PE was the most likely or equal most likely diagnosis showed meaningful 
discriminant value. Previous studies
16,17
 ƐƵŐŐĞƐƚĞĚƚŚĂƚƚŚĞtĞůů ?ƐWĐƌŝƚĞƌŝĂĐŽƵůĚďĞƵƐĞĚƚŽƌƵůĞ
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out PE in pregnancy, albeit based on small numbers with PE and imprecise estimates of sensitivity. 
Our study included many more cases with PE and showed that sensitivity was inadequate to rule out 
PE. The rules had sensitivities between 0.361 and 0.675 (apart from the sensitive rule) indicating that 
they would miss between one and two thirds of cases of PE. The sensitive rule had acceptable 
sensitivity to rule out PE but with specificity of 0.035 would not allow a rule-out for a meaningful 
proportion without PE.  
 
Finally we have shown that D-dimer is unable to discriminate between pregnant and postpartum 
women who have PE and those who do not. At both thresholds for positivity tested the sensitivity 
was similar to one minus the specificity. This indicates that the proportion with a positive D-dimer is 
similar in those with and without PE. Previous studies of D-dimer in pregnant women with suspected 
PE produced mixed results and imprecise estimates of accuracy
16-19
, but studies of suspected DVT in 
pregnancy suggested high sensitivity
20
 and acceptable specificity if a higher threshold for positivity 
was used
13
. Our study provides more precise estimates of accuracy for PE in pregnancy and suggests 
that D-dimer has no useful role in diagnosis. 
 
Table 5 shows how the clinical decision rules and D-dimer would classify a population of 1000 
women with suspected PE, of whom 65 had PE (based on the prevalence in the primary analysis 
population with suspected PE). All except the sensitive consensus rule and D-dimer would miss a 
substantial proportion of cases with PE, and both of these would be positive in a greater proportion 
of those without PE than those with PE. 
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It is important to recognise that our findings apply to the diagnostic assessment of suspected PE in 
pregnant and postpartum women referred for hospital investigation. They may reflect the processes 
used to select women for hospital investigation. For example, if women with minor symptoms and a 
recent history of long haul travel decide to attend or are advised to attend hospital while those with 
similar symptoms but no such history self-manage or seek care elsewhere, then this may explain 
why recent long haul travel appears to predict absence of PE in secondary care. Our study was not 
intended to identify risk factors for VTE in pregnancy and postpartum, so our findings should not be 
interpreted as challenging current knowledge about risk factors in pregnancy and postpartum, only 
their use as diagnostic markers in those receiving hospital investigation of suspected PE. 
 
Strengths and limitations 
The key strength and rationale for the study design was the large number of women with PE. We 
were able to estimate associations and diagnostic parameters with much greater precision than 
previous studies. We identified women with diagnosed PE from all UK hospitals with consultant-led 
maternity units and recruited women with suspected PE from a range of different settings, thus 
ensuring the generalisability of our findings. 
 
The increased power for measuring sensitivity came with an increased risk of bias, as seen in case-
control studies
10
. We attempted to minimise this by ensuring that the additional cases were 
representative of all diagnosed PE, not just the most severe cases, and that women without PE were 
representative of women presenting with suspected PE in whom the diagnosis is subsequently ruled 
out. The design related bias associated with case-control studies tends to inflate estimates of 
diagnostic accuracy, so would not undermine our conclusions that clinical features, decision rules 
and D-dimer have little diagnostic value. However, in our study design related bias may have had the 
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opposite effect. Although we asked research nurses to collect data from hospital records rather than 
the patient it is possible that they were able to use prospective data to more accurately identify 
clinical features (such as long haul travel and varicose veins) than the UKOSS clinicians who were 
entirely reliant upon hospital records. 
 
Our evaluation of clinical decision rules was limited by the need to adapt existing rules to the 
pregnant and postpartum population and apply the rules retrospectively to the study data. This led 
ƚŽĂŶƵŵďĞƌŽĨĂƐƐƵŵƉƚŝŽŶƐĂŶĚŝŶƚĞƌƉƌĞƚĂƚŝŽŶƐ ?ŵŽƐƚŶŽƚĂďůǇŝŶƚŚĞĂƉƉůŝĐĂƚŝŽŶŽĨƚŚĞtĞůů ?Ɛ
ĐƌŝƚĞƌŝŽŶ “/ƐWƚŚĞŵŽƐƚůŝŬĞůǇŽƌĞƋƵĂůůǇŵŽƐƚůŝŬĞůǇĚŝĂŐŶŽƐŝƐ ? ?dŚŝƐǁĂƐĚĞƚĞƌŵŝŶĞĚďǇŝŶƚĞƌƉƌĞƚŝŶŐ
the text of the clinical diagnostic impression. Although we attempted to ensure that this was the 
diagnostic impression recorded before imaging it is possible than in some cases of diagnosed PE this 
was recorded after ŝŵĂŐŝŶŐ ?dŚĞĂƉƉĂƌĞŶƚĚŝĂŐŶŽƐƚŝĐƐƵƉĞƌŝŽƌŝƚǇŽĨtĞůů ?ƐWĐƌŝƚĞƌŝĂŽǀĞƌŽƚŚĞƌ
clinical decision rules is highly dependent on this criterion so conclusions regarding the relative 
ƉĞƌĨŽƌŵĂŶĐĞŽĨƚŚĞtĞůů ?ƐWĐƌŝƚĞƌŝĂƐŚŽƵůĚďĞŵĂĚĞǁŝƚŚĐĂƵƚŝŽŶ ? Conversely, all of the rules may 
perform better if used prospectively rather than being retrospectively applied to collected data. 
 
Interpretation 
The practical implication of this study is that women presenting to secondary care with PE in 
pregnancy or postpartum suspected by their treating clinician should all receive imaging for PE. 
Although 42/324 (13%) of the women with suspected PE did not receive imaging the lack of adverse 
outcome in this modest number of cases provides little reassurance that they were safely managed. 
In the absence of a structured and validated means of selecting women for imaging we would expect 
guidelines to recommend imaging for all.  
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Further research is required to estimate the risks and benefits of imaging for PE in the pregnant and 
postpartum population and develop ways for clinicians to present this information to women in a 
comprehensible manner. Biomarkers other than D-dimer may be of value and could be the subject 
of future study. However, further research into clinical decision rules and D-dimer are unlikely to be 
worthwhile. The limitations of our study design are unlikely to explain the negative findings, 
suggesting that the effort and expense required to deliver a prospective cohort study is unlikely to 
be justified. 
 
CONCLUSION 
Clinical features, existing clinical decision rules and D-dimer have little diagnostic value and should 
not be used to select pregnant or postpartum women with suspected PE for diagnostic imaging. 
Chest x-ray abnormality, even if not considered to be PE-related, increases the likelihood of PE 
diagnosis.  
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Table 1: Comparison of characteristics between women with and without PE 
Basic demographics Women with 
PE 
Women 
without PE 
Univariate odds 
ratio (95% CI) 
Univariate 
P-Value 
Multivariate odds 
ratio (95% CI) 
Multivariate 
p-value 
Age over 35 years 37 (20.44%) 40 (15.44%) 1.41 (0.86-2.31) 0.176 - - 
Age (continuous) - - 1.02 (0.99-1.05) 0.179 1.06 (1.01-1.11) 0.026 
BMI 30 or more 60 (33.15%) 85 (32.82%) 1.01 (0.68-1.52) 0.942 - - 
BMI (Continuous) - - 1.01 (0.99-1.04) 0.372 1.03 (0.99- 1.07) 0.153 
Smoking 
Status 
never 116 (64.09%) 171 (66.02%) Reference - - - 
gave up before 28 (15.47%) 39 (15.06%) 1.06 (0.61-1.81) 0.837 1.09 (0.49-2.41) 0.828 
gave up during  23 (12.71%) 19 (7.34%) 1.78 (0.93-3.46) 0.082 2.35 (0.93-5.92) 0.070 
Current 14 (7.73%) 30 (11.58%) 0.69 (0.34-1.33) 0.279 1.17 (0.44-3.10) 0.755 
Previous pregnancies     
ш ?ƉƌĞǀŝŽƵƐƉƌĞŐŶĂŶĐǇф ? ?
weeks 
68 (37.57%) 97 (37.45%) 1.00 (0.68-1.49) 0.98 - - 
N of previous pregnancies < 
24 weeks (Continuous) 
- - 1.05 (0.91-1.23) 0.509 0.96 (0.79-1.18) 0.713 
ш ?ƉƌĞǀŝŽƵƐƉƌĞŐŶĂŶĐǇх ? ?
weeks 
126 (69.61%) 165 (63.71%) 1.30 (0.87-1.97) 0.198 - - 
N of previous pregnancies > 
24 weeks (Continuous) 
- - 1.20 (1.04-1.30) 0.017 0.94 (0.72-1.22) 0.636 
Previous Pr gnancy 
Problems 
55 (30.39%) 70 (27.03%) 1.18 (0.77-1.79) 0.442 1.17 (0.60-2.26) 0.646 
Previous medical problems     
Family history of thrombosis 24 (13.26%) 46 (17.76%) 0.71 (0.41-1.20) 0.205 0.35 (0.14-0.90) 0.029 
History of varicose veins 5 (2.76%) 19 (7.34%) 0.36 (0.12-0.91) 0.045 0.42 (0.09-1.86) 0.251 
History of IV drug use 1 (0.55%) 1 (0.39%) 1.43 (0.06-36.4) 0.8 0 1.0 
Known thrombophilia 4 (2.21%) 7 (2.70%) 0.81 (0.21-2.74) 0.745 0.12 (0.01-1.26) 0.077 
Surgery in previous 4 weeks 35 (19.34%) 21 (8.11%) 2.72 (1.53-4.92) 0.001 0.85 (0.30-2.40) 0.753 
Significant injury in the 
previous 4 weeks 
2 (1.10%) 3 (1.16%) 0.95 (0.12-5.81) 0.959 0.42 (0.03-5.45) 0.505 
History of thrombosis 19 (10.50%) 15 (5.79%) 1.91 (0.95-3.92) 0.073 3.07 (1.05-8.99) 0.041 
Other previous medical 
problem 
75 (41.44%) 110 (42.47%) 0.96 (0.65-1.41) 0.829 - - 
Other previous medical 
problem (VTE-related) 
4 (2.21%) 6 (2.32%) 1.02 (0.26-3.62) 0.978 0.94 (0.16-5.61) 0.946 
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Current pregnancy     
1st Trimester 15 (8.29%) 20 (7.72%) Reference - - - 
2nd Trimester 37 (20.44%) 79 (30.50%) 0.62 (0.29-1.37) 0.234 0.81 (0.28-2.30) 0.693 
3rd Trimester 60 (33.15%) 116 (44.79%) 0.69 (0.33-1.46) 0.324 0.59 (0.21-1.64) 0.310 
Post-Partum 63 (34.81%) 44 (16.99%) 1.91 (0.89-4.19) 0.101 1.63 (0.51-5.23) 0.407 
Multiple pregnancy 4 (2.21%) 12 (4.63%) 0.47 (0.13-1.36) 0.191 0.13 (0.01-1.22) 0.074 
Long-haul travel during 
pregnancy 
2 (1.10%) 21 (8.11%) 0.13 (0.02-0.44) 0.006 0 1.0 
3 or more days of 
immobility/bed rest  
14 (7.73%) 21 (8.11%) 0.95 (0.46-1.91) 0.887 0.85 (0.29-2.54) 0.774 
Previous thrombotic event 
this pregnancy 
5 (2.76%) 3 (1.16%)
  
2.44 (0.59-1.20) 0.226 4.22 (0.49-36.1) 0.189 
Other problems with this 
pregnancy 
74 (40.88%) 73 (28.19%) 1.46 (0.97-2.20) 0.067 - - 
Other problems with this 
pregnancy (VTE-related) 
15 (8.29%) 19 (7.34%) 1.14 (0.56-2.31) 0.713 1.05 (0.34-3.17) 0.938 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 2: Comparison of presenting features, physiology, ECG and chest x-ray between 
women with and without PE 
 
Presenting feature Women with 
PE 
Women 
without PE 
Univariate odds 
ratio (95% CI) 
Univariate 
P-Value 
Multivariate odds 
ratio (95%CI) 
Multivariate 
p-value 
Presenting feature: 
Pleuritic chest pain 
94 (51.93%) 137 (52.90%) 0.96 (0.66-1.41) 0.842 1.30 (0.69-2.45) 0.418 
Presenting feature: Non-
pleuritic chest pain 
38 (20.99%) 47 (18.15%) 1.20 (0.74-1.93) 0.457 1.23 (0.57-2.67) 0.596 
Presenting feature: 
Shortness of breath at 
rest 
97 (53.59%) 157 (60.62%) 0.75 (0.51-1.10) 0.142 0.70 (0.40-1.24) 0.223 
Presenting feature: 
Shortness of breath  on 
exertion 
93 (51.38%) 125 (48.26%) 1.13 (0.77-1.66) 0.52 1.60 (0.91-2.81) 0.104 
Presenting feature: 
Haemoptysis 
13 (7.18%) 10 (3.86%) 1.93 (0.83-4.61) 0.129 2.90 (0.84-10.1) 0.093 
Presenting feature: Cough 16 (8.84%) 23 (8.88%) 1.00 (0.50-1.93) 0.988 0.38 (0.12-1.21) 0.102 
Presenting feature: 
Syncope 
9 (4.97%) 7 (2.70%) 1.88 (0.69-5.36) 0.218 2.79 (0.57-13.5) 0.203 
Presenting feature: 
Palpitations 
24 (13.26%) 30 (11.58%) 1.17 (0.65-2.07) 0.598 1.44 (0.53-3.87) 0.472 
Presenting feature: Other 62 (34.25%) 90 (34.75%) 0.98 (0.65-1.46) 0.914 0.61 (0.32-1.17) 0.140 
Temperature > 37.5 14 (7.73%) 7 (2.70%) 3.02 (1.23-8.11) 0.02 - - 
Temperature 
(Continuous) 
  1.75 (1.22-2.57) 0.003 2.22 (1.26-3.91) 0.006 
Diastolic < 50 mmHg 4 (2.21%) 2 (0.77%) 2.90 (0.56-21.1) 0.221 - - 
Diastolic (Continuous)   1.01 (0.99-1.03) 0.256 1.03 (0.99-1.06) 0.122 
Systolic < 90 mmHg 3 (1.66%) 1 (0.39%) 4.35 (0.55-88.3) 0.205 - - 
Systolic (Continuous)   0.99 (0.98-1.01) 0.322 0.96 (0.93-0.99) 0.004 
O2 Saturation < 94% 27 (14.92%) 10 (3.86%) 4.37 (2.12-9.71) <0.001 - - 
O2 Saturation 
(Continuous) 
  0.85 (0.78-0.92) <0.001 0.87 (0.78-0.97) 0.012 
Respiratory Rate > 24/min 18 (9.94%) 25 (9.65%) 1.03 (0.54-1.95) 0.919 - - 
Respiratory Rate 
(Continuous) 
  1.00 (0.96-1.04) 0.948 0.94 (0.88-1.02) 0.136 
Heart rate >100/min 55 (30.39%) 72 (27.80%) 1.13 (0.75-1.72) 0.556 - - 
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(110/min 3
rd
 trimester) 
Heart Rate (Continuous)   1.01 (0.99-1.02) 0.126 1.01 (0.99-1.03) 0.153 
Clinical signs of DVT 23 (12.71%) 23 (8.88%) 1.49 (0.81-2.77) 0.199 1.63 (0.61-4.35) 0.325 
PE related ECG 
abnormality 
4 (2.21%) 8 (3.09%) 0.71 (0.19-2.29) 0.579 0.823 (0.40-1.69) 0.596 
PE related chest x-ray 
abnormality 
30 (16.57%) 18 (6.95%) 15.20 (2.82-
282.0) 
0.01 13.4 (1.39-130.2) 0.025 
Other chest x-ray 
abnormality 
9 (4.97%) 1 (0.39%) 2.82 (1.53-5.33) 0.001 2.49 (0.93-6.69) 0.069 
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Table 3: Comparison of continuous clinical variables between women with and without 
PE 
 
Mean (SD) Women with PE Women without PE 
Age (years) 30.2 (6.20) 29.4 (5.94) 
BMI (kg/m
2
) 28.7 (7.56) 28 (6.54) 
Heart rate (/min) 98.3 (19.7) 95.5 (17.7) 
Respiratory rate (/min) 19.0 (5.04) 19.0 (4.42) 
Oxygen saturation (%) 96.5 (4.36) 97.8 (1.82) 
Systolic BP (mmHg) 121 (17.0) 123 (15.7) 
Diastolic BP (mmHg) 74.2 (12.3) 72.9 (11.7) 
Temperature (degrees C) 36.8 (0.60) 36.6 (0.83) 
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Table 4: Diagnostic accuracy of the clinical decision rules 
 
Decision rule AUROC using full range 
of score values 
95% CI 
Sensitivity at usual or 
recommended 
threshold 
95% CI 
n/N 
Specificity at usual or 
recommended 
threshold 
95% CI 
n/N 
Primary consensus 0.626 
0.572 to 0.681 
0.609 
0.532 to 0.683 
103/169 
0.585 
0.523 to 0.646 
151/258 
Sensitive consensus 0.620 
0.566 to 0.675 
0.959 
0.917 to 0.983 
162/169 
0.035 
0.016 to 0.065 
9/258 
Specific consensus 0.589 
0.537 to 0.642 
0.361 
0.289 to 0.438 
61/169 
0.783 
0.728 to 0.832 
202/258 
PERC 0.621 
0.570 to 0.672 
0.675 
0.598 to 0.745 
114/169 
0.519 
0.457 to 0.582 
134/258 
Simplified Revised 
Geneva 
0.579 
0.526 to 0.632 
0.444 
0.368 to 0.522 
75/169 
0.636 
0.574 to 0.694 
164/258 
tĞůů ?Ɛ ?ƉĞƌŵŝƐƐŝǀĞ ? ? 0.577 
0.522 to 0.632 
0.490 
0.410 to 0.571 
77/157 
0.617 
0.553 to 0.678 
153/248 
tĞůů ?Ɛ ?ƐƚƌŝĐƚ ? ? 0.732 
0.682 to 0.782 
0.376 
0.300 to 0.457 
59/157 
0.895 
0.850 to 0.930 
222/248 
 ?tĞůů ?ƐĐƌŝƚĞƌŝĂǁĞƌĞƚĞƐƚĞĚƵƐŝŶŐĂůŝďĞƌĂů ?ƉĞƌŵŝƐƐŝǀĞ ?ŝŶƚĞƌƉƌĞƚĂƚŝŽŶŽĨĐůŝŶŝĐĂůĚŝĂŐŶŽƐŝƐƚĞǆƚƚŽ 
determine whether PE was the most likely or equal most likely diagnosis and a more strict 
interpretation 
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Table 5: Implementation of the clinical decision rules and D-dimer 
 
Assessment PE correctly 
identified 
(true positive) 
PE missed 
(false negative) 
PE correctly 
ruled out 
(true negative) 
PE incorrectly 
diagnosed 
(false positive) 
Primary consensus rule 
 
40 25 547 388 
Sensitive consensus rule 
 
62 3 33 902 
Specific consensus rule 
 
23 42 732 203 
PERC rule 
 
44 21 485 450 
Simplified Revised 
Geneva score 
29 36 595 340 
tĞůů ?ƐƐĐŽƌĞ
(permissive) 
32 33 577 358 
tĞůů ?ƐƐĐŽƌĞ ?ƐƚƌŝĐƚ ? 
 
24 41 837 98 
D-dimer (conventional 
threshold) 
57 8 82 853 
D-dimer (pregnancy-
specific threshold) 
45 20 307 628 
The table shows how a population of 1000 women, of whom 65 had PE, would be classified by the 
clinical decision rules and D-dimer 
 
